156 related articles for article (PubMed ID: 36478908)
21. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
Lu D; Sun L; Li Z; Mu Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
[TBL] [Abstract][Full Text] [Related]
23. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling.
Zhang P; Guo H; Zhao F; Jia K; Yang F; Liu X
Open Med (Wars); 2023; 18(1):20220567. PubMed ID: 36852267
[TBL] [Abstract][Full Text] [Related]
24. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
[TBL] [Abstract][Full Text] [Related]
25. lncRNA RHPN1-AS1 promotes the progression of endometrial cancer through the activation of ERK/MAPK pathway.
Zhang XJ; Qi GT; Zhang XM; Wang L; Li FF
J Obstet Gynaecol Res; 2021 Feb; 47(2):533-543. PubMed ID: 33169491
[TBL] [Abstract][Full Text] [Related]
26. TRIB3 suppresses proliferation and invasion and promotes apoptosis of endometrial cancer cells by regulating the AKT signaling pathway.
Qu J; Liu B; Li B; Du G; Li Y; Wang J; He L; Wan X
Onco Targets Ther; 2019; 12():2235-2245. PubMed ID: 30988628
[TBL] [Abstract][Full Text] [Related]
27. Low Levels of SPARC are Associated with Tumor Progression and Poor Prognosis in Human Endometrial Carcinoma.
Wang L; Wang W; Xu Y; Wang Q
Onco Targets Ther; 2020; 13():11549-11569. PubMed ID: 33204109
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
30. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
[TBL] [Abstract][Full Text] [Related]
32. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway.
Wang Y; Yin L; Sun X
J Exp Clin Cancer Res; 2020 Aug; 39(1):169. PubMed ID: 32847606
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
34. miR-15b, a diagnostic biomarker and therapeutic target, inhibits oesophageal cancer progression by regulating the PI3K/AKT signalling pathway.
Liu J; Xu H; Wang N; Sun M
Exp Ther Med; 2020 Dec; 20(6):222. PubMed ID: 33363587
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathway.
Ci C; Wu C; Lyu D; Chang X; He C; Liu W; Chen L; Ding W
Clin Exp Dermatol; 2020 Mar; 45(2):194-201. PubMed ID: 31419330
[TBL] [Abstract][Full Text] [Related]
36.
Bhandari A; Xia E; Zhou Y; Guan Y; Xiang J; Kong L; Wang Y; Yang F; Wang O; Zhang X
Cancer Manag Res; 2018; 10():969-976. PubMed ID: 29760566
[TBL] [Abstract][Full Text] [Related]
37. Mitogenic and anti-apoptotic effects of insulin in endometrial cancer are phosphatidylinositol 3-kinase/Akt dependent.
Wang Y; Hua S; Tian W; Zhang L; Zhao J; Zhang H; Zhang W; Xue F
Gynecol Oncol; 2012 Jun; 125(3):734-41. PubMed ID: 22426488
[TBL] [Abstract][Full Text] [Related]
38. Downregulating integrin subunit alpha 7 (ITGA7) promotes proliferation, invasion, and migration of papillary thyroid carcinoma cells through regulating epithelial-to-mesenchymal transition.
Guan Y; Bhandari A; Xia E; Kong L; Zhang X; Wang O
Acta Biochim Biophys Sin (Shanghai); 2020 Feb; 52(2):116-124. PubMed ID: 31942970
[TBL] [Abstract][Full Text] [Related]
39. CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway.
Liu Y; Chang Y; He X; Cai Y; Jiang H; Jia R; Leng J
Front Oncol; 2020; 10():1525. PubMed ID: 32984001
[No Abstract] [Full Text] [Related]
40. Rapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting
Liu T; Liang X; Sun Y; Yang S
Exp Ther Med; 2021 Oct; 22(4):1190. PubMed ID: 34475980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
